BIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthaler
Episode
40 min
Read time
2 min
Topics
Career Growth, Relationships, Leadership
AI-Generated Summary
Key Takeaways
- ✓Pre-event targeting: Biotechs should map their disease area and development stage against the 20–40 pharma companies with publicly known pipelines in that space, then identify specific attending individuals via LinkedIn and the conference attendee list — not just company names — weeks before the event to build a structured meeting skeleton.
- ✓Cost and timing discipline: Conference costs are predictable months in advance — flight prices, hotel availability, and ticket early-bird discounts are all time-sensitive. Lanthaler frames late booking as a strategic failure: BIO's date and location are known a year out, so teams should lock in travel and registration three or more months ahead to control budget.
- ✓Profile completion via AI: Filling out partnering system company profiles is non-negotiable for maximizing meeting requests. Lanthaler dismisses the "too much work" objection entirely — any AI tool can generate a complete profile from a single prompt, removing the effort barrier and ensuring the company appears in relevant search results within the platform.
- ✓Meeting framing: A 20–30 minute partnering meeting should be positioned as the opening of a relationship, not a pitch session. Presenting 150 slides is the wrong approach. The goal is to surface the real obstacles and value proposition quickly in person, since in-person dialogue allows faster course correction than email or legal back-and-forth ever can.
- ✓Follow-up within one week: Any meeting worth pursuing requires follow-up within seven days of the conference. No response within 14 days typically signals low priority rather than rejection. Lanthaler recommends re-attempting contact across multiple conference cycles, noting that most successful venture rounds and BD deals required several separate initiation attempts before timing aligned.
What It Covers
Werner Lanthaler, former Evotec CEO who scaled the company from 200 employees and €40M to 5,000 staff and €800M revenue, shares practical strategies for biotechs attending the BIO International Convention in San Diego, covering preparation, on-site execution, and post-event follow-up to convert meetings into partnerships.
Key Questions Answered
- •Pre-event targeting: Biotechs should map their disease area and development stage against the 20–40 pharma companies with publicly known pipelines in that space, then identify specific attending individuals via LinkedIn and the conference attendee list — not just company names — weeks before the event to build a structured meeting skeleton.
- •Cost and timing discipline: Conference costs are predictable months in advance — flight prices, hotel availability, and ticket early-bird discounts are all time-sensitive. Lanthaler frames late booking as a strategic failure: BIO's date and location are known a year out, so teams should lock in travel and registration three or more months ahead to control budget.
- •Profile completion via AI: Filling out partnering system company profiles is non-negotiable for maximizing meeting requests. Lanthaler dismisses the "too much work" objection entirely — any AI tool can generate a complete profile from a single prompt, removing the effort barrier and ensuring the company appears in relevant search results within the platform.
- •Meeting framing: A 20–30 minute partnering meeting should be positioned as the opening of a relationship, not a pitch session. Presenting 150 slides is the wrong approach. The goal is to surface the real obstacles and value proposition quickly in person, since in-person dialogue allows faster course correction than email or legal back-and-forth ever can.
- •Follow-up within one week: Any meeting worth pursuing requires follow-up within seven days of the conference. No response within 14 days typically signals low priority rather than rejection. Lanthaler recommends re-attempting contact across multiple conference cycles, noting that most successful venture rounds and BD deals required several separate initiation attempts before timing aligned.
Notable Moment
Lanthaler challenges the assumption that VCs close deals at large biotech conventions, calling that expectation overblown. He argues most financing rounds require separate, dedicated introductions outside the conference format — and that BIO functions primarily as a business development event, not a fundraising platform.
You just read a 3-minute summary of a 37-minute episode.
Get Beyond Biotech summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from Beyond Biotech
Advancing corticosteroids and hormonal therapies for supply and scale
Jun 12 · 27 min
Lenny's Podcast
10 contrarian leadership truths every leader needs to hear | Matt MacInnis (Rippling)
Dec 28
More from Beyond Biotech
Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media
Jun 5 · 43 min
Latent Space
Railway: The Agent-Native Cloud — Jake Cooper
May 20
More from Beyond Biotech
We summarize every new episode. Want them in your inbox?
Advancing corticosteroids and hormonal therapies for supply and scale
Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media
World MS Day Special: Immunic reveals new hope for progressive MS
The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Freeze variability, not progress: strengthen your cell therapy supply chain from the start
Similar Episodes
Related episodes from other podcasts
Lenny's Podcast
Dec 28
10 contrarian leadership truths every leader needs to hear | Matt MacInnis (Rippling)
Latent Space
May 20
Railway: The Agent-Native Cloud — Jake Cooper
Equity
Jan 2
How AI is reshaping work and who gets to do it, according to Mercor's CEO
No Priors: Artificial Intelligence | Technology | Startups
Dec 5
Scaling Legal AI and Building Next-Generation Law Firms with Harvey Co-Founder and President Gabe Pereyra
a16z Podcast
Jun 17
The Fintech Playbook for Latin America
Explore Related Topics
This podcast is featured in Best Biotech Podcasts (2026) — ranked and reviewed with AI summaries.
You're clearly into Beyond Biotech.
Every Monday, we deliver AI summaries of the latest episodes from Beyond Biotech and 192+ other podcasts. Free for up to 3 shows.
Start My Monday DigestNo credit card · Unsubscribe anytime